Skip to content

Clinical trials

Musculoskeletal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Clear all

747 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20043
20059
20062
20072
20083
200918
20107
201112
201213
201320
201430
201531
201631
201734
201846
201945
202051
202166
202282
202362
202456
202560
202642

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed411
Unknown status110
Recruiting83
Terminated35
Not yet recruiting34
Active, not recruiting33
Withdrawn21
Enrolling by invitation15
Suspended2
No longer available1
Available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Research Centre for the Working Environment, Denmark14
AbbVie13
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio13
Afyonkarahisar Health Sciences University10
Chinese University of Hong Kong10
BioMarin Pharmaceutical8
Cairo University8
QED Therapeutics, a BridgeBio company8
Al-Azhar University7
University of Pittsburgh7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases747
Joint Diseases97
Arthritis76
Osteoarthritis63
Rheumatic Diseases51
Bone Diseases47
Nervous System Diseases38
Pain38
Genetic Diseases, Inborn37
Osteoarthritis, Knee37

Trials

Showing 76 to 100 of 747. Each trial links to its page on Pharma Observatory.

647 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.